MedTrace Logo

A Double-Masked Comparison of FID 123320 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness

NCT06444529 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 159

Last updated 2025-10-23

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of Apraclonidine Hydrochloride Ophthalmic Solution 0.125% when compared to Vehicle, in relieving redness of the eye due to minor eye irritations. This study will be conducted in the United States.

Conditions

  • Ocular Redness

Interventions

DRUG

Apraclonidine Hydrochloride Ophthalmic Solution

Investigational ophthalmic solution applied topically to the eye with a dropper bottle

DRUG

Vehicle

Vehicle (inactive ingredients) applied topically to the eye with a dropper bottle

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Principal Clinical Trial Lead, Pharma · Alcon Research, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-21
Primary Completion
2024-11-14
Completion
2025-01-08
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06444529 on ClinicalTrials.gov